Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. OSIS
9. BJ
10. DE

Go back to Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial
(NASDAQ: KROS) Delayed: 10.83 -0.12 (1.1%)
Previous Close $10.95    52 Week High $ 
Open $10.96    52 Week Low $ 
Day High $11.09    P/E N/A 
Day Low $10.82    EPS $ 
Volume 38,873